Flucytosine

Abstract
Orally administered flucytosine appeared to successfully eradicate chromomycosis in three patients. The duration of therapy should be adequate for complete clinical and mycological evidence of cure. Flucytosine is easily administered and the untoward effects are minor, infrequent, and easily reversible. Flucytosine appears to be a major improvement over prior therapy for this chronic and progressive disease.

This publication has 4 references indexed in Scilit: